AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Zicla-M Tablet

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Zicla-M Tablet

Diabeta-Duo tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabeta-Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continue taking this medication even if feeling well or experiencing controlled blood sugar; abrupt cessation, without medical consultation, risks elevated blood glucose and complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, Diabeta-Duo complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are crucial in diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation, and vomiting. Carry readily available glucose (e.g., sugary snacks or juice) to counter hypoglycemia; consistent meal timing is also important. Alcohol consumption elevates hypoglycemia risk and should be avoided. Less frequent side effects can include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabeta-Duo is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Uses of Zicla-M Tablet

Adult-onset diabetes

Major Benefits of Zicla-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Zicla-M Tablets should be administered with a meal.

Common Side effects of Zicla-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Zicla-M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Zicla-M Tablets should be administered with a meal.

How Zicla-M Tablet works:

Zicla-M tablets contain a dual-action formulation of gliclazide and metformin, both medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Zicla-M Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Zicla-M Tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Zicla-M tablets while breastfeeding carries a likely risk. Available human data indicates potential transfer of the medication into breast milk, posing a possible threat to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Zicla-M tablets, potentially requiring dosage modifications. Severe kidney disease contraindicates Zicla-M tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Zicla-M Tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, Zicla-M Tablets are typically initiated at a low dosage; however, their use is contraindicated in those with severe liver disease.

What if you forget to take Zicla-M Tablet :

Should you forget a Zicla-M Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Zicla-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Zicla-M Tablet

Zicla-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Zicla-M is not suitable for type 1 diabetes.
Zicla-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Zicla-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Zicla-M Tablet can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in individuals with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Zicla-M and seek immediate medical attention.
Prolonged Zicla-M Tablet use can lead to vitamin B12 deficiency by impairing its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some research.
Zicla-M Tablets are contraindicated in patients with allergies to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Zicla-M Tablet and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Zicla-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Zicla-M is not suitable for type 1 diabetes.
Zicla-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Zicla-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Zicla-M Tablet use can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Zicla-M Tablet and seek immediate medical attention.
Prolonged Zicla-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zicla-M Tablets are contraindicated in patients allergic to any component or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Zicla-M Tablet and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Zicla-M Tablet
130
MRP 151
13% off